October 16, 2017 — An article in USA Today discusses the high costs associated with a new gene therapy treatment. Kymriah, a leukemia drug, has a high initial cost that rises even higher because of associated treatments, such as those to manage side effects. The article quotes Dr. Gellad, who notes that Read More »